7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Angiotensin Receptor Blockers
Angiotensin Receptor Blockers (ARBs) play a crucial role in the field of cardiovascular medicine by targeting the renin-angiotensin-aldosterone system. These medications, also known as angiotensin II receptor antagonists, work by blocking the action of angiotensin II on specific receptors, thereby dilating blood vessels and reducing the workload on the heart. ARBs are commonly prescribed to manage conditions such as hypertension, heart failure, and diabetic nephropathy. By modulating the effects of angiotensin II, ARBs contribute to blood pressure regulation and the overall well-being of individuals with cardiovascular concerns. Their distinct mechanism of action and efficacy make ARBs a valuable class of drugs in the therapeutic arsenal against cardiovascular diseases, offering patients a targeted and effective approach to managing their health.
Yochai Birnbaum
Baylor College of Medicine, United States
Uwe Peter Tigor
Auxilius Pharma, United States, United States
Federico Benetti
Benetti Foundation, Argentina
Sergey Suchkov
Professor in Medicine & Immunology, Director for Center for Biodesign of N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Syed Raza
Awali Hospital, Bahrain
Sekib Sokolovic
ASA Hospital Sarajevo, Bosnia and Herzegowina
Thomas J Webster
Brown University, United StatesSubmit your abstract Today
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Precision nutrition for heart health: A personalized approach to cardiovascular disease prevention and management
Teji Dhami, BOOST your Health and Wellness, United States